Elliott Investment Management’s CorMedix CRMD Stock Holding History

Elliott Investment Management’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,444,561	Closed	-$15.1M	–	34
2025 Q1	$15.1M	Sell	2,444,561 -426,071	-15%	-$4.41M	0.1%	36
2024 Q4	$23.3M	Buy	2,870,632 +1,320,109	+85%	+$13.2M	0.14%	34
2024 Q3	$12.5M	Hold	1,550,523	–	–	0.06%	51
2024 Q2	$6.71M	Hold	1,550,523	–	–	0.04%	52
2024 Q1	$6.57M	Hold	1,550,523	–	–	0.04%	52
2023 Q4	$5.83M	Hold	1,550,523	–	–	0.03%	56
2023 Q3	$5.74M	Hold	1,550,523	–	–	0.04%	58
2023 Q2	$6.15M	Hold	1,550,523	–	–	0.05%	57
2023 Q1	$6.42M	Hold	1,550,523	–	–	0.05%	47
2022 Q4	$6.54M	Hold	1,550,523	–	–	0.05%	50
2022 Q3	$4.39M	Hold	1,550,523	–	–	0.05%	38
2022 Q2	$6.23M	Hold	1,550,523	–	–	0.07%	38
2022 Q1	$8.5M	Hold	1,550,523	–	–	0.09%	40
2021 Q4	$7.05M	Hold	1,550,523	–	–	0.06%	42
2021 Q3	$7.21M	Hold	1,550,523	–	–	0.05%	44
2021 Q2	$10.6M	Hold	1,550,523	–	–	0.08%	46
2021 Q1	$15.5M	Sell	1,550,523 -207,851	-12%	-$2.19M	0.12%	50
2020 Q4	$13.1M	Hold	1,758,374	–	–	0.13%	46
2020 Q3	$10.6M	Buy	1,758,374 +925,000	+111%	+$4.65M	0.11%	43
2020 Q2	$5.25M	Hold	833,374	–	–	0.06%	40
2020 Q1	$2.99M	Buy	+833,374	New	+$4.71M	0.06%	46

Other funds holding CRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

GCM

Ghisallo Capital Management Boston, Massachusetts $3.63B AUM 30.51% 1-Year Est. Return

Elliott Investment Management's CRMD Position: Q2 2025 in Review

Elliott Investment Management sold out of CorMedix (CRMD) in Q2 2025, closing a stake of 2,444,561 shares — an estimated $15.1M sold.

Elliott Investment Management first reported a position in CRMD in Q1 2020 and held it in 21 quarters. The position peaked at $23.3M in Q4 2024. 172 funds tracked by Wall St. Rank hold CRMD as of Q2 2025.

Elliott Investment Management reported no remaining CorMedix position as of Q2 2025 after selling out during the quarter.
Elliott Investment Management sold 2,444,561 CorMedix shares in Q2 2025, an estimated $15.1M.
Elliott Investment Management first reported a position in CorMedix in Q1 2020 and held it in 21 quarters.
Elliott Investment Management's CorMedix position peaked at $23.3M in Q4 2024.
172 funds tracked by Wall St. Rank held CorMedix as of Q2 2025.

Based on Elliott Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.